Apellis Pharmaceuticals, Inc. Liquidation Value
APLS
Other
Cash & Equivalents
$466.23M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $466.23M
Total Obligations: -$342.63M
$123.60M
Per share: $0.98
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $466.23M
AR: $366.22M
Total Obligations: -$342.63M
$489.82M
Per share: $3.87
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $466.23M
AR: $366.22M
Inventory: $142.56M
Total Obligations: -$342.63M
$632.38M
Per share: $4.99
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $123.60M | $0.98 |
| Liquid Liquidation Value | $489.82M | $3.87 |
| Operating Liquidation Value | $632.38M | $4.99 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $466.23M |
| Accounts Receivable | $366.22M |
| Inventory | $142.56M |
| Current Liabilities | $323.60M |
| Long-term Debt | N/A |
| Op. Lease Liability | $19.03M |
| Finance Lease | N/A |
| Shares Outstanding | 126.6M |
Explore all 170 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $466.23M | $366.22M | $142.56M | $56.80M | $323.60M | N/A | $19.03M | N/A |
| 2025-09-30 | $479.17M | $345.54M | $122.82M | $38.60M | $279.53M | N/A | $20.70M | N/A |
| 2025-06-30 | $370.04M | $214.13M | $121.00M | $54.24M | $200.66M | N/A | $15.73M | N/A |
| 2025-03-31 | $358.39M | $235.25M | $82.47M | $55.29M | $178.38M | N/A | $16.13M | N/A |
▼ Community Notes